SUBSCRIBE
SUBSCRIBE
Genetown

ArQule, Inc. to Present at 13th Annual Biotechnology Industry Organization (BIO) CEO and Investor Conference

February 8, 2011 | 
1 min read
WOBURN, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the 13th Annual BIO CEO and Investor Conference on Monday, February 14, 2011 at 2:00 p.m. eastern time.
Events
Biotechnology Innovation Organization (BIO)
MORE ON THIS TOPIC
Control, Fluctuation, Uncertainty, Businessman balancing with an umbrella
Rare diseases
Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor
April 2, 2026
 · 
6 min read
 · 
Heather McKenzie
Orlando, Florida
Immunology and inflammation
AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases
March 31, 2026
 · 
4 min read
 · 
Tristan Manalac
Social media networking. Network with members connected with each other. Group of people. Communication, teamwork, community, society. Abstract concept with wooden pieces on blue background.
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
February 13, 2026
 · 
6 min read
 · 
Heather McKenzie
Viral vector, gene therapy, DNA delivery. Virus inserting genetic material into a cell nucleus. Gene editing, therapeutic genes, engineering, genetic diseases, dna, CRISPR, biotechnology. Medicine 3D illustration
Gene therapy
In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego
February 11, 2026
 · 
4 min read
 · 
Heather McKenzie